Annual CFO
-$981.03 K
+$586.07 K+37.40%
31 December 2023
Summary:
Chromocell Therapeutics annual cash flow from operations is currently -$981.03 thousand, with the most recent change of +$586.07 thousand (+37.40%) on 31 December 2023. During the last 3 years, it has risen by +$611.97 thousand (+38.42%). CHRO annual CFO is now at all-time high.CHRO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$177.91 K
+$2.77 M+93.97%
30 September 2024
Summary:
Chromocell Therapeutics quarterly cash flow from operations is currently -$177.91 thousand, with the most recent change of +$2.77 million (+93.97%) on 30 September 2024. Over the past year, it has increased by +$178.90 thousand (+50.14%). CHRO quarterly CFO is now -2.60% below its all-time high of -$173.40 thousand, reached on 01 March 2023.CHRO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$5.48 M
+$79.29 K+1.43%
30 September 2024
Summary:
Chromocell Therapeutics TTM cash flow from operations is currently -$5.48 million, with the most recent change of +$79.29 thousand (+1.43%) on 30 September 2024. Over the past year, it has dropped by -$4.50 million (-458.51%). CHRO TTM CFO is now -1459.64% below its all-time high of -$351.30 thousand, reached on 01 March 2022.CHRO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHRO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +50.1% | -458.5% |
| 3 y3 years | +38.4% | - | - |
| 5 y5 years | - | - | - |
CHRO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.4% | -2.6% | +94.0% | -1459.6% | +1.4% |
| 5 y | 5 years | at high | +72.9% | -2.6% | +94.0% | -1459.6% | +1.4% |
| alltime | all time | at high | +72.9% | -2.6% | +94.0% | -1459.6% | +1.4% |
Chromocell Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$177.91 K(-94.0%) | -$5.48 M(-1.4%) |
| June 2024 | - | -$2.95 M(+48.2%) | -$5.56 M(+98.5%) |
| Mar 2024 | - | -$1.99 M(+458.3%) | -$2.80 M(+185.4%) |
| Dec 2023 | -$981.03 K | -$356.81 K(+38.7%) | -$981.01 K(-24.0%) |
| Sept 2023 | - | -$257.20 K(+32.9%) | -$1.29 M(-0.0%) |
| June 2023 | - | -$193.60 K(+11.6%) | -$1.29 M(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$173.40 K(-74.0%) | -$1.39 M(-11.4%) |
| Dec 2022 | -$1.57 M(-1.6%) | -$666.60 K(+158.6%) | -$1.57 M(+74.0%) |
| Sept 2022 | - | -$257.80 K(-11.5%) | -$900.50 K(+40.1%) |
| June 2022 | - | -$291.40 K(-17.1%) | -$642.70 K(+82.9%) |
| Mar 2022 | - | -$351.30 K | -$351.30 K |
| Dec 2021 | -$1.59 M(-56.1%) | - | - |
| Dec 2020 | -$3.63 M | - | - |
FAQ
- What is Chromocell Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly CFO year-on-year change?
- What is Chromocell Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Chromocell Therapeutics?
- What is Chromocell Therapeutics TTM CFO year-on-year change?
What is Chromocell Therapeutics annual cash flow from operations?
The current annual CFO of CHRO is -$981.03 K
What is the all time high annual CFO for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual cash flow from operations is -$981.03 K
What is Chromocell Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CHRO is -$177.91 K
What is the all time high quarterly CFO for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly cash flow from operations is -$173.40 K
What is Chromocell Therapeutics quarterly CFO year-on-year change?
Over the past year, CHRO quarterly cash flow from operations has changed by +$178.90 K (+50.14%)
What is Chromocell Therapeutics TTM cash flow from operations?
The current TTM CFO of CHRO is -$5.48 M
What is the all time high TTM CFO for Chromocell Therapeutics?
Chromocell Therapeutics all-time high TTM cash flow from operations is -$351.30 K
What is Chromocell Therapeutics TTM CFO year-on-year change?
Over the past year, CHRO TTM cash flow from operations has changed by -$4.50 M (-458.51%)